Rights Ratio | Face Value | Premium | Ex-Right Date | Record Date | Announcement Date |
|---|---|---|---|---|---|
| No data found | |||||
*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.
Existing shareholders of Bliss GVS Pharma as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
Shareholders can apply for Bliss GVS Pharma rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
No! Participation in Bliss GVS Pharma rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
No, Bliss GVS Pharma hasn’t had any right issues as of {{current_date}} in last 2023-2025
No, Bliss GVS Pharma hasn’t had any right issues as of {{current_date}} in last 2023-2025